Argentina approves Sputnik Light Covid-19 shot as standalone and booster
Sputnik Light showed effectiveness as a universal boost when mixed with the vaccines of AstraZeneca, Sinopharm, Moderna and Cansino.
Infectious Diseases
Canada enters deals to procure Merck and Pfizer’s Covid-19 antiviral pills
Pfizer anticipates supplying one million courses of its investigational oral pill through next year.
FDA grants EUA to Lilly’s Covid-19 antibody therapy for paediatric use
The EUA has been granted based on safety and efficacy data from the BLAZE-1 trial...
Narrow FDA panel vote on Merck’s molnupiravir bolsters outlook on mAbs
A close FDA committee vote to authorize molnupiravir indicates that mAbs could still be favored...
UK’s MHRA grants authorisation for GSK-Vir Biotechnology’s Covid-19 drug
MHRA has recommended the use of GSK and Vir Biotechnology’s Xevudy within five days from...
Oravax Medical to test triple antigen oral vaccine against Omicron
The vaccine candidate is expected to be used as an independent vaccine or as a booster drug for people vaccinated earlier.
Italy approves Pfizer and BioNTech’s Covid-19 vaccine for children
The dosage for children is indicated to be a third of the authorised 30µg dose given to adults and adolescents.
RedHill Biopharma reports rise in Q3 2021 net revenues
Talicia reported a 15% increase in new prescriptions and a 117% rise compared to the third quarter of last year.
UAE approves Sputnik Light vaccine as universal booster dose for Covid-19
The Sputnik Light vaccine can be administered six months after the second dose of all other vaccines used in the UAE.
First Wave BioPharma to continue Covid-19 GI infection therapy trial
The DMC recommendation was based on the review of positive safety data from the first 25 patients dosed in Part 2 of the trial.
Omicron variant minimally impacts Gritstone’s Covid-19 vaccines
Only 2% of the 146 non-Spike TCEs given within the vaccine currently in trials in the UK and US were affected by Omicron.
